IMPORTANT DRUG WARNING[removed]Higher incidence of new cases of ovarian failure observed in premenopausal women treated with Avastin® (bevacizumab) Dear Healthcare Provider: - Histoplasmosis - Document - PDFSEARCH.IO

First Page	Meta Content
	IMPORTANT DRUG WARNING[removed]Higher incidence of new cases of ovarian failure observed in premenopausal women treated with Avastin® (bevacizumab) Dear Healthcare Provider: Add to Reading List Document Date: 2014-03-31 07:24:10 Open Document File Size: 204,17 KB Share Result on Facebook Company Roche Group / Development Chief Medical Officer Genentech Inc. / Genentech USA Inc. / M.D. / / Country United States / / Event FDA Phase / / IndustryTerm treatment of patients with colon cancer / treatment for stage II/III colon cancer / mFOLFOX6-treated / / MedicalCondition colon cancer / stage II/III colon cancer / metastatic renal cell carcinoma / metastatic carcinoma / small cell lung cancer / / MedicalTreatment chemotherapy / / Organization FDA / / Person Hal Barron / / / Position Executive Vice President / / Product carboplatin / Avastin / fluorouracil / paclitaxel / mFOLFOX6 / / Technology chemotherapy / / URL www.accessdata / / SocialTag Menstrual cycle Ovarian cancer Colorectal cancer Vascular endothelial growth factor Renal cell carcinoma Menopause Presumed ocular histoplasmosis syndrome Medicine Bevacizumab Genentech

IMPORTANT DRUG WARNING[removed]Higher incidence of new cases of ovarian failure observed in premenopausal women treated with Avastin® (bevacizumab) Dear Healthcare Provider:Add to Reading List